TELA Bio (TELA) Research & Development (2018 - 2026)

TELA Bio has reported Research & Development for 9 years, with the latest figure at $2.3 million in Q1 2026.

• For the quarter ending Q1 2026, Research & Development fell 7.76% year-over-year to $2.3 million; the trailing twelve-month figure through Mar 2026 stood at $9.0 million (up 0.7% YoY), and the FY2025 full-year result was $9.2 million, up 4.62% from the prior year.
• Research & Development for Q1 2026 stood at $2.3 million, up from $2.1 million in the prior quarter.
• The five-year high for Research & Development was $2.7 million in Q4 2022, with the low at $2.0 million in Q1 2022.
• Average Research & Development over 5 years is $2.3 million, with a median of $2.3 million recorded in 2024.
• Year-over-year, Research & Development surged 58.03% in 2022 and retreated 24.43% in 2024.
• Tracing TELA's Research & Development over 5 years: stood at $2.7 million in 2022, then slipped by 1.5% to $2.7 million in 2023, then fell by 24.43% to $2.0 million in 2024, then gained by 4.93% to $2.1 million in 2025, then gained by 10.05% to $2.3 million in 2026.
• The last three Research & Development figures came in at $2.3 million (Q1 2026), $2.1 million (Q4 2025), and $2.3 million (Q3 2025), per Business Quant data.

Peer Comparison